Vibalogics is creating a 110,000-sf facility for the production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products in Boxborough, Mass.

Thor Sciences is retrofitting an eight-story, 350,000-sf structure to create 95G, a lab-ready research facility in Jersey City.

Boylston Properties and J.P. Morgan Asset Management began construction in January of 2021 on a 165,600-sf life sciences facility in Watertown, Mass.

Civica Rx began construction in early 2021 on a $124.5 million pharmaceutical manufacturing center in Petersburg, Va.

BioMed Realty is planning to create a life sciences innovation campus in Somerville, Mass.

The Massachusetts Center for Advanced Biological Innovation and Manufacturing is planning to create a 40,000-sf facility in Watertown, Mass.

Canadian developer Oxford Properties has expanded its real estate portfolio in the United States with the acquisition of four new assets.

Silverstein Properties & Cantor Fitzgerald are partnering with University Place Associates to create a biomedical innovation center in Philade

BioMed Realty is creating a 482,000-sf life sciences hub in Boston's Seaport District.

Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.